IL22 and hepatocellular carcinoma: Although direct research on HCC is currently limited, FMT may indirectly inhibit the development and progression of HCC through mechanisms such as regulating the IL-22/IL-17 balance, repairing the intestinal barrier, and reversing microbiota dysbiosis.